These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 29110630)

  • 1. Genotoxicity of 4-(piperazin-1-yl)-8-(trifluoromethyl)pyrido[2,3-e][1,2,4] triazolo[4,3-a]pyrazine, a Potent H4 Receptor Antagonist for the Treatment of Allergy: Evidence of Glyoxal Intermediate Involvement.
    Gunduz M; Cirello AL; Klimko P; Dumouchel JL; Argikar UA
    Drug Metab Lett; 2017; 11(2):144-148. PubMed ID: 29110630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotoxicity of 2-(3-chlorobenzyloxy)-6-(piperazinyl)pyrazine, a novel 5-hydroxytryptamine2c receptor agonist for the treatment of obesity: role of metabolic activation.
    Kalgutkar AS; Dalvie DK; Aubrecht J; Smith EB; Coffing SL; Cheung JR; Vage C; Lame ME; Chiang P; McClure KF; Maurer TS; Coelho RV; Soliman VF; Schildknegt K
    Drug Metab Dispos; 2007 Jun; 35(6):848-58. PubMed ID: 17344339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming the genotoxicity of a pyrrolidine substituted arylindenopyrimidine as a potent dual adenosine A(2A)/A(1) antagonist by minimizing bioactivation to an iminium ion reactive intermediate.
    Lim HK; Chen J; Sensenhauser C; Cook K; Preston R; Thomas T; Shook B; Jackson PF; Rassnick S; Rhodes K; Gopaul V; Salter R; Silva J; Evans DC
    Chem Res Toxicol; 2011 Jul; 24(7):1012-30. PubMed ID: 21667953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spectrum of enzymes involved in activation of 2-aminoanthracene varies with the metabolic system applied.
    Veres Z; Török G; Tóth E; Vereczkey L; Jemnitz K
    Mutat Res; 2005 Sep; 586(1):18-27. PubMed ID: 16006184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
    Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
    Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotoxic bioactivation of constituents of a diesel exhaust particle extract by the human lung.
    Iba MM; Caccavale RJ
    Environ Mol Mutagen; 2013 Apr; 54(3):158-71. PubMed ID: 23400972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif.
    Kalgutkar AS; Driscoll J; Zhao SX; Walker GS; Shepard RM; Soglia JR; Atherton J; Yu L; Mutlib AE; Munchhof MJ; Reiter LA; Jones CS; Doty JL; Trevena KA; Shaffer CL; Ripp SL
    Chem Res Toxicol; 2007 Dec; 20(12):1954-65. PubMed ID: 17935300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternatives in the induction and preparation of phenobarbital/naphthoflavone-induced S9 and their activation profiles.
    García Franco S; Domínguez G; Pico JC
    Mutagenesis; 1999 May; 14(3):323-6. PubMed ID: 10375000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel series of histamine H4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: comparison of hERG binding and target residence time with PF-3893787.
    Andaloussi M; Lim HD; van der Meer T; Sijm M; Poulie CB; de Esch IJ; Leurs R; Smits RA
    Bioorg Med Chem Lett; 2013 May; 23(9):2663-70. PubMed ID: 23558237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide bond-forming reagents HOAt and HATU are not mutagenic in the bacterial reverse mutation test.
    Nicolette J; Neft RE; Vanosdol J; Murray J
    Environ Mol Mutagen; 2016 Apr; 57(3):236-40. PubMed ID: 26840011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450.
    Hales BF
    Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of biotransformation products of disperse dyes with rat liver microsomes by LC-MS/MS and theoretical studies with DNA: Structure-mutagenicity relationship using Salmonella/microsome assay.
    Franco JH; Silva BFD; Oliveira RV; Meireles G; de Oliveira DP; Castro AA; Ramalho TC; Zanoni MVB
    Sci Total Environ; 2018 Feb; 613-614():1093-1103. PubMed ID: 28950671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism-dependent mutagenicity of a compound containing a piperazinyl indazole motif: Role of a novel p450-mediated metabolic reaction involving a putative oxaziridine intermediate.
    Chen H; Murray J; Kornberg B; Dethloff L; Rock D; Nikam S; Mutlib AE
    Chem Res Toxicol; 2006 Oct; 19(10):1341-50. PubMed ID: 17040103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical basis for differences in metabolism-dependent genotoxicity by two diazinylpiperazine-based 5-HT2C receptor agonists.
    Kalgutkar AS; Bauman JN; McClure KF; Aubrecht J; Cortina SR; Paralkar J
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1559-63. PubMed ID: 19246199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro genotoxicity of para-phenylenediamine and its N-monoacetyl or N,N'-diacetyl metabolites.
    Garrigue JL; Ballantyne M; Kumaravel T; Lloyd M; Nohynek GJ; Kirkland D; Toutain H
    Mutat Res; 2006 Sep; 608(1):58-71. PubMed ID: 16807077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of metabolic activation mixtures containing human hepatic post-mitochondrial supernatant (S9) for in vitro genetic toxicity assessment.
    Cox JA; Fellows MD; Hashizume T; White PA
    Mutagenesis; 2016 Mar; 31(2):117-30. PubMed ID: 26712374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a new scaffold to develop potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
    Colotta V; Lenzi O; Catarzi D; Varano F; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Pugliese AM; Traini C; Pedata F; Morizzo E; Moro S
    J Med Chem; 2009 Apr; 52(8):2407-19. PubMed ID: 19301821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation of the metabolism of N-nitroso-N-methylaniline by phenobarbital- and pyrazole-induced Sprague-Dawley rat liver and esophagus derived S-9.
    Gold B; Farber J; Rogan E
    Chem Biol Interact; 1987 Mar; 61(3):215-28. PubMed ID: 3568192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of prazosin in rat, dog, and human liver microsomes and cryopreserved rat and human hepatocytes and characterization of metabolites by liquid chromatography/tandem mass spectrometry.
    Erve JC; Vashishtha SC; DeMaio W; Talaat RE
    Drug Metab Dispos; 2007 Jun; 35(6):908-16. PubMed ID: 17353349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greater effectiveness of hepatocyte and liver S9 preparations from hamsters than rat preparations in activating N-nitroso compounds to metabolites mutagenic to Salmonella.
    Raineri R; Poiley JA; Andrews AW; Pienta RJ; Lijinsky W
    J Natl Cancer Inst; 1981 Nov; 67(5):1117-22. PubMed ID: 6946249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.